Field trials and tribulations—making sense of the regulations for experimental field trials of transgenic crops in Europe
Gómez Galera, Sonia
Twyman, Richard M.
Sparrow, Penelope A.C.
Van Droogenbroeck, Bart
MetadataShow full item record
Transgenic plants that are being developed for commercial cultivation must be tested underfield conditions to monitor their effects on surrounding wildlife and conventional crops. Devel-opers also use this opportunity to evaluate the performance of transgenic crops in a typicalenvironment, although this is a matter of commercial necessity rather than regulatory compli-ance. Most countries have adapted existing regulations or developed new ones to deal specif-ically with transgenic crops and their commodities. The European Union (EU) is renowned, orperhaps notorious, for having the broadest and most stringent regulations governing suchfield trials in the world. This reflects its nominal adherence to the precautionary approach,which assumes all transgenic crops carry an inherent risk. Therefore, field trials in the EU needto demonstrate that the risk associated with deploying a transgenic crop has been reduced tothe level where it is regarded as acceptable within the narrowly defined limits of the regula-tions developed and enforced (albeit inconsistently) by national and regional governments,that is, that there is no greater risk than growing an equivalent conventional crop. Theinvolvement of national and regional competent authorities in the decision-making processcan add multiple layers of bureaucracy to an already-intricate process. In this review, we usecountry-based case studies to show how the EU, national and regional regulations are imple-mented, and we propose strategies that could increase the efficiency of regulation withoutburdening developers with further unnecessary bureaucracy.
Is part ofPlant Biotechnology Journal, 2012, vol. 10, núm. 5, p. 511-523
European research projects
Except where otherwise noted, this item's license is described as by (c) Sonia Gómez Galera et al., 2012
Showing items related by title, author, creator and subject.
The contribution of transgenic plants to better health through improved nutrition: opportunities and constraints Pérez Massot, Eduard; Banakar, Raviraj; Gómez Galera, Sonia; Zorrilla López, Uxue; Sanahuja Solsona, Georgina; Arjó Pont, Gemma; Miralpeix i Anglada, Bruna; Vamvaka, Evangelia; Farré Martinez, Gemma; Rivera Vélez, Sol Maiam; Dashevskaya, Svetlana; Berman Quintana, Judit; Sabalza Gallués, Maite; Yuan, Dawei; Bai, Chao; Bassie Rene, Ludovic; Twyman, Richard M.; Capell Capell, Teresa; Christou, Paul; Zhu, Changfu (Springer Verlag, 2013)Malnutrition is a prevalent and entrenched global socioeconomic challenge that reflects the combined impact of poverty, poor access to food, inefficient food distribution infrastructure, and an over-reliance on ...
Peremartí, Ariadna; Twyman, Richard M.; Gómez Galera, Sonia; Naqvi, Shaista; Farré Martinez, Gemma; Sabalza Gallués, Maite; Miralpeix i Anglada, Bruna; Dashevskaya, Svetlana; Yuan, Dawei; Ramessar, Koreen; Christou, Paul; Zhu, Changfu; Bassie Rene, Ludovic; Capell Capell, Teresa (Springer Verlag, 2010)Multigene transformation (MGT) is becoming routine in plant biotechnology as researchers seek to generate more complex and ambitious phenotypes in transgenic plants. Every nuclear transgene requires its own promoter, ...
Capell Capell, Teresa; Zhu, Changfu; Bassie Rene, Ludovic; Peremartí, Ariadna; Naqvi, Shaista; Ramessar, Koreen; Gómez Galera, Sonia; Christou, Paul (Institut d'Estudis Catalans. Secció de Ciències i Tecnologia, 2007)Les plantes transgèniques són una part integral de l’agricultura contemporània. Durant l’any 2006 més de noranta milions d’hectàrees de plantes transgèniques van ser cultivades en vint-i-un països. Des de la comercialització ...